Brieflands
Journal finderSearch
·
Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Home
Articles
    Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
About Journal
    Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Hepatitis Monthly
  6. /
  7. Articles
  8. /
  9. Coincidental Occurrence of Hepatocellular Carcinoma and Cholangiocarcinoma (Collision Tumors) After Liver Transplantation: A Case Report
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

5 results·Updated October 10, 2026
← Back to article
1

Hepatocellular carcinoma-cholangiocarcinoma collision tumor with excellent therapeutic response: a case report and literature review

Discover Oncology

December 2026

Sun Z.

Open Access

2

Challenges in Diagnosing and Reporting Cholangiocarcinoma

Surgical Pathology Clinics

September 2023

El Jabbour T.

3

Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review

Surgery Today

1 August 2017

Gupta R.

4

Association of upregulated HMGB1 and c-IAP2 proteins with hepatocellular carcinoma development and progression

Hepatitis Monthly

15 December 2014

Bi M.R.

Open Access

5

Different faces of hepatocellular carcinoma as a health threat in 21st century

Hepatitis Monthly

February 2013

Yeganeh B.

Open Access

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.